vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and TRUSTCO BANK CORP N Y (TRST). Click either name above to swap in a different company.

TRUSTCO BANK CORP N Y is the larger business by last-quarter revenue ($49.5M vs $38.9M, roughly 1.3× CODEXIS, INC.). TRUSTCO BANK CORP N Y runs the higher net margin — 32.9% vs 24.7%, a 8.2% gap on every dollar of revenue. Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs 6.8%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

TRUSTCO BANK CORP N Y is a regional U.S. financial holding company that provides a full suite of retail and commercial banking products and services, including personal deposit accounts, mortgage loans, small business financing, and wealth management solutions. It primarily operates across New York, Florida, and several other U.S. states, serving individual consumers and small business client segments.

CDXS vs TRST — Head-to-Head

Bigger by revenue
TRST
TRST
1.3× larger
TRST
$49.5M
$38.9M
CDXS
Higher net margin
TRST
TRST
8.2% more per $
TRST
32.9%
24.7%
CDXS
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
6.8%
TRST

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CDXS
CDXS
TRST
TRST
Revenue
$38.9M
$49.5M
Net Profit
$9.6M
$16.3M
Gross Margin
94.8%
Operating Margin
27.1%
Net Margin
24.7%
32.9%
Revenue YoY
81.3%
Net Profit YoY
192.5%
14.1%
EPS (diluted)
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
TRST
TRST
Q1 26
$49.5M
Q4 25
$38.9M
$48.2M
Q3 25
$8.6M
$47.8M
Q2 25
$15.3M
$46.6M
Q1 25
$7.5M
$45.3M
Q4 24
$21.5M
$43.3M
Q3 24
$12.8M
$43.6M
Q2 24
$8.0M
$43.4M
Net Profit
CDXS
CDXS
TRST
TRST
Q1 26
$16.3M
Q4 25
$9.6M
$15.6M
Q3 25
$-19.6M
$16.3M
Q2 25
$-13.3M
$15.0M
Q1 25
$-20.7M
$14.3M
Q4 24
$-10.4M
$11.3M
Q3 24
$-20.6M
$12.9M
Q2 24
$-22.8M
$12.6M
Gross Margin
CDXS
CDXS
TRST
TRST
Q1 26
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Operating Margin
CDXS
CDXS
TRST
TRST
Q1 26
Q4 25
27.1%
43.7%
Q3 25
-220.3%
44.6%
Q2 25
-83.9%
42.3%
Q1 25
-271.6%
41.3%
Q4 24
-34.2%
34.0%
Q3 24
-129.0%
38.8%
Q2 24
-284.9%
37.9%
Net Margin
CDXS
CDXS
TRST
TRST
Q1 26
32.9%
Q4 25
24.7%
32.3%
Q3 25
-228.1%
34.0%
Q2 25
-86.6%
32.3%
Q1 25
-274.3%
31.5%
Q4 24
-48.4%
26.0%
Q3 24
-160.8%
29.5%
Q2 24
-285.2%
28.9%
EPS (diluted)
CDXS
CDXS
TRST
TRST
Q1 26
Q4 25
$0.13
$0.85
Q3 25
$-0.22
$0.86
Q2 25
$-0.16
$0.79
Q1 25
$-0.25
$0.75
Q4 24
$-0.12
$0.59
Q3 24
$-0.29
$0.68
Q2 24
$-0.32
$0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
TRST
TRST
Cash + ST InvestmentsLiquidity on hand
$78.2M
Total DebtLower is stronger
$40.1M
$112.9M
Stockholders' EquityBook value
$50.5M
$670.9M
Total Assets
$147.8M
$6.5B
Debt / EquityLower = less leverage
0.79×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
TRST
TRST
Q1 26
Q4 25
$78.2M
$730.4M
Q3 25
$58.7M
$695.6M
Q2 25
$66.3M
$713.6M
Q1 25
$59.8M
$756.1M
Q4 24
$73.5M
$641.8M
Q3 24
$90.3M
$523.0M
Q2 24
$73.2M
$536.1M
Total Debt
CDXS
CDXS
TRST
TRST
Q1 26
$112.9M
Q4 25
$40.1M
Q3 25
$39.7M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
Q3 24
$28.6M
Q2 24
$28.4M
Stockholders' Equity
CDXS
CDXS
TRST
TRST
Q1 26
$670.9M
Q4 25
$50.5M
$686.6M
Q3 25
$38.5M
$692.0M
Q2 25
$55.6M
$692.8M
Q1 25
$49.6M
$687.8M
Q4 24
$66.9M
$676.3M
Q3 24
$73.4M
$669.0M
Q2 24
$61.4M
$655.2M
Total Assets
CDXS
CDXS
TRST
TRST
Q1 26
$6.5B
Q4 25
$147.8M
$6.4B
Q3 25
$124.0M
$6.3B
Q2 25
$138.2M
$6.3B
Q1 25
$128.9M
$6.3B
Q4 24
$149.0M
$6.2B
Q3 24
$148.2M
$6.1B
Q2 24
$132.0M
$6.1B
Debt / Equity
CDXS
CDXS
TRST
TRST
Q1 26
0.17×
Q4 25
0.79×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
Q2 24
0.46×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
TRST
TRST
Operating Cash FlowLast quarter
$20.1M
Free Cash FlowOCF − Capex
$19.6M
FCF MarginFCF / Revenue
50.3%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
2.09×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
TRST
TRST
Q1 26
Q4 25
$20.1M
$57.6M
Q3 25
$-7.7M
$12.8M
Q2 25
$-18.0M
$27.1M
Q1 25
$-13.8M
$1.3M
Q4 24
$-16.5M
$59.4M
Q3 24
$-13.0M
$16.5M
Q2 24
$-12.2M
$18.7M
Free Cash Flow
CDXS
CDXS
TRST
TRST
Q1 26
Q4 25
$19.6M
$45.7M
Q3 25
$-7.9M
$10.0M
Q2 25
$-20.5M
$24.9M
Q1 25
$-15.1M
$-3.3M
Q4 24
$-18.2M
$54.6M
Q3 24
$-14.0M
$15.6M
Q2 24
$-12.6M
$17.6M
FCF Margin
CDXS
CDXS
TRST
TRST
Q1 26
Q4 25
50.3%
95.0%
Q3 25
-91.7%
20.9%
Q2 25
-133.6%
53.5%
Q1 25
-199.6%
-7.2%
Q4 24
-85.0%
126.0%
Q3 24
-109.0%
35.7%
Q2 24
-157.5%
40.5%
Capex Intensity
CDXS
CDXS
TRST
TRST
Q1 26
Q4 25
1.3%
24.6%
Q3 25
2.1%
5.9%
Q2 25
16.4%
4.5%
Q1 25
16.7%
10.0%
Q4 24
8.3%
11.3%
Q3 24
7.8%
2.1%
Q2 24
5.0%
2.6%
Cash Conversion
CDXS
CDXS
TRST
TRST
Q1 26
Q4 25
2.09×
3.70×
Q3 25
0.79×
Q2 25
1.80×
Q1 25
0.09×
Q4 24
5.27×
Q3 24
1.28×
Q2 24
1.49×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CDXS
CDXS

Segment breakdown not available.

TRST
TRST

Net Interest Income$44.7M90%
Noninterest Income$4.8M10%

Related Comparisons